GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $991,000 | +45.7% | 22,872 | +85.5% | 0.00% | +33.3% |
| Q3 2020 | $680,000 | -13.5% | 12,330 | -0.9% | 0.00% | -25.0% |
| Q2 2020 | $786,000 | +13.7% | 12,443 | -8.0% | 0.00% | 0.0% |
| Q1 2020 | $691,000 | -60.3% | 13,526 | -38.2% | 0.00% | -55.6% |
| Q4 2019 | $1,741,000 | -30.3% | 21,904 | -57.5% | 0.01% | -35.7% |
| Q3 2019 | $2,499,000 | +7.2% | 51,495 | +16.1% | 0.01% | +7.7% |
| Q2 2019 | $2,332,000 | +15.0% | 44,341 | +15.8% | 0.01% | +8.3% |
| Q1 2019 | $2,027,000 | +653.5% | 38,298 | +483.8% | 0.01% | +500.0% |
| Q4 2018 | $269,000 | -22.7% | 6,560 | -28.3% | 0.00% | 0.0% |
| Q3 2018 | $348,000 | -11.0% | 9,150 | +5.8% | 0.00% | -33.3% |
| Q2 2018 | $391,000 | -32.1% | 8,650 | -27.5% | 0.00% | -25.0% |
| Q1 2018 | $576,000 | – | 11,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |